跳至主要内容
临床试验/NCT07213596
NCT07213596尚未招募不适用

Development of Virtual Reality Treatment Technology to Treat Trauma Related to COVID-19 Infection

Soonchunhyang University Hospital0 个研究点目标入组 100 人开始时间: 2025年11月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
100
主要终点
Change in PTSD symptoms

研究概览

简要总结

This clinical trial aims to develop and evaluate the effectiveness of virtual reality (VR)-based exposure therapy for trauma symptoms related to COVID-19 infection. The intervention targets healthcare workers and individuals from the general population who experienced pandemic-related psychological distress. The study assesses psychological and physiological outcomes, including PTSD, anxiety, depression, HRV, and EEG biomarkers.

详细描述

The project involves a two-phase clinical study. In Phase 1, VR exposure therapy content is developed based on trauma management theory and tailored to specific participant groups (e.g., COVID-19 survivors, healthcare workers). In Phase 2, randomized controlled trials will compare VR treatment with standard therapy approaches (CBT, supportive therapy) across two populations:

Healthcare workers involved in the care of COVID-19 patients Members of the general public affected by social disaster-related psychological distress

Participants will undergo 5 weekly sessions of VR exposure therapy. Pre- and post-intervention assessments will include standardized psychiatric scales (e.g., PHQ-9, PCL-5), HRV, and EEG measurements. The trial aims to validate the efficacy and safety of customized VR therapy protocols and identify relevant biomarkers for treatment prediction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-64, healthy population who survived from COVID-19 (COVID survivors) or Healthcare Workers with PCL-5 ≥10, GAD-7/PHQ-9 ≥10

排除标准

  • Pregnancy, neurological disorders, severe medical conditions

结局指标

主要结局

Change in PTSD symptoms

时间窗: baseline, week 5, 3-mo follow-up

Change in PTSD symptoms (PCL-5/CAPS-5) at baseline, week 5, 3-mo follow-up

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ji Sun Kim

Professor

Soonchunhyang University Hospital

相似试验

Virtual Reality Treatment for Trauma Related to... | 临床试验